Profile
Mr. Marcus Irsfeld is a Chief Financial Officer & Executive Director at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Artract Medical, Inc. Mr. Irsfeld was previously employed as a Chief Financial Officer by ProCorde GmbH and a Controller by Trigen Holdings AG.
He received his undergraduate degree from the University of Münster.
Marcus Irsfeld active positions
| Companies | Position | Start |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director of Finance/CFO | 30/11/2025 |
Artract Medical, Inc.
Artract Medical, Inc. Medical SpecialtiesHealth Technology Manufactures hemodynamic assist device | Founder | - |
Former positions of Marcus Irsfeld
| Companies | Position | End |
|---|---|---|
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Comptroller/Controller/Auditor | 14/12/2009 |
ProCorde GmbH
ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Develops biomedical drugs for cardiovascular diseases | Director of Finance/CFO | 10/04/2005 |
Training of Marcus Irsfeld
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ProCorde GmbH
ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Develops biomedical drugs for cardiovascular diseases | Commercial Services |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Commercial Services |
University of Münster
University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Artract Medical, Inc.
Artract Medical, Inc. Medical SpecialtiesHealth Technology Manufactures hemodynamic assist device | Health Technology |
- Stock Market
- Insiders
- Marcus Irsfeld
















